Antidiabetic Agents and Bone Quality: A Focus on Glycation End Products and Incretin Pathway Modulations
Muthanna K. Zaki, Mohammed N. Abed, Fawaz A. Alassaf
J Bone Metab. 2024;31(3):169-181.   Published online 2024 Aug 31     DOI: https://doi.org/10.11005/jbm.2024.31.3.169
Citations to this article as recorded by Crossref logo
The microbial metabolite imidazole propionate dysregulates bone homeostasis by inhibiting AMP-activated protein kinase (AMPK) signaling
Suk-Gyun Park, Jung-Woo Kim, Ju Han Song, Seung-Hee Kwon, Sin-Hye Oh, Xianyu Piao, Zhao Wang, Je-Hwang Ryu, Nacksung Kim, Ok-Su Kim, Jeong-Tae Koh
Communications Biology.2024;[Epub]     CrossRef